About this episode
In this era of a pandemic, why do we need the placebo controls for regulatory agency or Food and Drug Administration (FDA)-approved clinical trials aimed at COVID-19 patients? The answer is always that we have to establish a ruler with a baseline onto which efficacy measurements can be statistically judged.
Get every episode summarized
Each time PubReading publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from PubReading
PubReading [346] - Transparency Is the Key to Quality - A. Fosang & R. Colbran
PubReading
Jul 3, 202313:40pending
PubReading [343] - The changing career trajectories of new parents in STEM - E....
PubReading
Jun 26, 202328:43pending
PubReading [341] - Carbon Nanomaterials (CNMs) in Cancer Therapy- A Database of...
PubReading
Jun 21, 202328:44pending
PubReading [340] - The application of human tissue for drug discovery and develo...
PubReading
Jun 19, 202323:32pending